首页 > 最新文献

Acta Gastroenterologica Latinoamericana最新文献

英文 中文
Prevalencia de regurgitación infantil: experiencia del grupo de trabajo en trastornos del eje cerebro-intestino de la Sociedad Latinoamericana de Gastroenterología, Hepatología y Nutrición Pediátrica (SLAGHNP) 儿童反流患病率:拉丁美洲胃肠病学、肝病和儿科营养学会脑肠轴疾病工作组的经验
Q4 Medicine Pub Date : 2023-03-30 DOI: 10.52787/agl.v53i1.280
Carlos Alberto Velasco-Benitez, Steven Koremblun Murillo, Claudia Jimena Ortíz-Rivera, Edgar Játiva Mariño, Fátima Azereth Reynoso Zarzosa, Mariana Xail Espriu Ramírez, Jorge Alberto Macías-Flores, Roberto Arturo Zablah Córdova, Ricardo A. Chanis Águila, Trini Fragoso Arbelo, Milton Danilo Mejía Castro, Yunuen Rivera Suazo
Introducción. La prevalencia de regurgitación infantil en niños latinoamericanos está entre el 8% y el 9,4% según los criterios de Roma III. Objetivo. Determinar la prevalencia de regurgitación infantil en niños latinoamericanos según los criterios de Roma IV y sus posibles asociaciones. Materiales y métodos. Estudio observacional, descriptivo, de prevalencia, realizado en siete países latinoamericanos. Se utilizó la base de datos de la Functional International Digestive Epidemiological Research Survey para seleccionar la muestra. Se incluyeron en el estudio niños menores de 12 meses que fueron diagnosticados con regurgitación infantil mediante el Cuestionario de Síntomas Gastrointestinales Pediátricos Roma IV. Resultados. Se analizaron 1802 lactantes (80,7% de América del Sur; 6,7±3,8 meses de edad). Se diagnosticó regurgitación infantil en 6,8% (52,5% mujeres; 39,8% mestizos; 46,7% colombianos). La edad pico fue 6 meses de vida. Hubo mayor probabilidad de presentar regurgitación infantil en los lactantes entre 1 y 6 meses de edad, de raza indígena, de Centroamérica, nacidos por cesárea, prematuros, atendidos en instituciones públicas, por gastroenterólogos pediatras y durante la pandemia del Covid-19. Hubo menor probabilidad de presentar regurgitación infantil en los lactantes con alimentación complementaria. Conclusión. La regurgitación infantil es frecuente en lactantes latinoamericanos. La prevalencia es menor comparativamente a lo descripto en otros países, con factores de riesgo como raza, origen, cesárea, prematuridad, sitio y nivel de atención, y pandemia de COVID-19. El factor protector es la alimentación complementaria.
介绍。根据罗马III标准,拉丁美洲儿童反流的患病率在8%至9.4%之间。目标。根据罗马IV标准确定拉丁美洲儿童反流的患病率及其可能的关联。材料和方法。在七个拉丁美洲国家进行的观察性、描述性流行研究。采用国际功能消化流行病学研究调查数据库选取样本。我们纳入了12个月以下通过儿科胃肠症状问卷(Roma IV)诊断为儿童反流的儿童。1802名婴儿(80.7%来自南美;6.7±3.8月龄)。6.8%的儿童被诊断为反流(52.5%为女性;梅蒂斯39.8%;哥伦比亚46,7%)。年龄峰值为6个月。1至6个月大、土著、中美洲、剖腹产、早产儿、公共机构、儿科胃肠病学专家和Covid-19大流行期间出现婴儿反流的可能性较高。补充喂养的婴儿出现婴儿反流的可能性较低。结论。婴儿反流在拉丁美洲的婴儿中很常见。与其他国家相比,患病率较低,风险因素包括种族、出身、剖腹产、早产、护理地点和水平以及COVID-19大流行。保护因素是补充喂养。
{"title":"Prevalencia de regurgitación infantil: experiencia del grupo de trabajo en trastornos del eje cerebro-intestino de la Sociedad Latinoamericana de Gastroenterología, Hepatología y Nutrición Pediátrica (SLAGHNP)","authors":"Carlos Alberto Velasco-Benitez, Steven Koremblun Murillo, Claudia Jimena Ortíz-Rivera, Edgar Játiva Mariño, Fátima Azereth Reynoso Zarzosa, Mariana Xail Espriu Ramírez, Jorge Alberto Macías-Flores, Roberto Arturo Zablah Córdova, Ricardo A. Chanis Águila, Trini Fragoso Arbelo, Milton Danilo Mejía Castro, Yunuen Rivera Suazo","doi":"10.52787/agl.v53i1.280","DOIUrl":"https://doi.org/10.52787/agl.v53i1.280","url":null,"abstract":"Introducción. La prevalencia de regurgitación infantil en niños latinoamericanos está entre el 8% y el 9,4% según los criterios de Roma III. Objetivo. Determinar la prevalencia de regurgitación infantil en niños latinoamericanos según los criterios de Roma IV y sus posibles asociaciones. Materiales y métodos. Estudio observacional, descriptivo, de prevalencia, realizado en siete países latinoamericanos. Se utilizó la base de datos de la Functional International Digestive Epidemiological Research Survey para seleccionar la muestra. Se incluyeron en el estudio niños menores de 12 meses que fueron diagnosticados con regurgitación infantil mediante el Cuestionario de Síntomas Gastrointestinales Pediátricos Roma IV. Resultados. Se analizaron 1802 lactantes (80,7% de América del Sur; 6,7±3,8 meses de edad). Se diagnosticó regurgitación infantil en 6,8% (52,5% mujeres; 39,8% mestizos; 46,7% colombianos). La edad pico fue 6 meses de vida. Hubo mayor probabilidad de presentar regurgitación infantil en los lactantes entre 1 y 6 meses de edad, de raza indígena, de Centroamérica, nacidos por cesárea, prematuros, atendidos en instituciones públicas, por gastroenterólogos pediatras y durante la pandemia del Covid-19. Hubo menor probabilidad de presentar regurgitación infantil en los lactantes con alimentación complementaria. Conclusión. La regurgitación infantil es frecuente en lactantes latinoamericanos. La prevalencia es menor comparativamente a lo descripto en otros países, con factores de riesgo como raza, origen, cesárea, prematuridad, sitio y nivel de atención, y pandemia de COVID-19. El factor protector es la alimentación complementaria.","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135419737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Buenas prácticas endoscópicas surgidas de la actividad conjunta SAGE-ENDIBA 2019 y los indicadores de calidad en endoscopía de ASGE 来自SAGE-ENDIBA 2019联合活动和ASGE内窥镜质量指标的良好内窥镜实践
Q4 Medicine Pub Date : 2021-09-27 DOI: 10.52787/QCAJ6371
Laudanno Om
{"title":"Buenas prácticas endoscópicas surgidas de la actividad conjunta SAGE-ENDIBA 2019 y los indicadores de calidad en endoscopía de ASGE","authors":"Laudanno Om","doi":"10.52787/QCAJ6371","DOIUrl":"https://doi.org/10.52787/QCAJ6371","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48192556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vólvulo de ciego con lesión de colon ascendente reporte de un caso y alternativas de tratamiento 盲肠扭转合并升结肠损伤1例报告及治疗选择
Q4 Medicine Pub Date : 2021-09-27 DOI: 10.52787/SUYI2286
G. Sosa, A. Barrios
right hemicolectomy with transverse ileus anastomosis, but if the volvulus caused intestinal necrosis and the patient is hemodynamically unstable, it is safer to perform intestinal resection and ileostomy. Ascending ileus anastomosis performed at a higher level of the ascending colon is a safe alterna-tive for the restitution of intestinal transit in patients with cecal volvulus.
右半结肠切除术伴回肠横向吻合术,但如果肠扭转导致肠坏死,且患者血流动力学不稳定,则进行肠切除和回肠造口术更安全。在较高的升结肠水平上进行上行回肠吻合是盲肠扭转患者恢复肠道运输的安全替代方案。
{"title":"Vólvulo de ciego con lesión de colon ascendente reporte de un caso y alternativas de tratamiento","authors":"G. Sosa, A. Barrios","doi":"10.52787/SUYI2286","DOIUrl":"https://doi.org/10.52787/SUYI2286","url":null,"abstract":"right hemicolectomy with transverse ileus anastomosis, but if the volvulus caused intestinal necrosis and the patient is hemodynamically unstable, it is safer to perform intestinal resection and ileostomy. Ascending ileus anastomosis performed at a higher level of the ascending colon is a safe alterna-tive for the restitution of intestinal transit in patients with cecal volvulus.","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43793390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparación entre los criterios diagnósticos del síndrome de intestino irritable en una población latinoamericana. Estudio descriptivo de un centro de atención terciaria 拉丁美洲人群肠易激综合征诊断标准的比较。三级保健中心的描述性研究
Q4 Medicine Pub Date : 2021-06-21 DOI: 10.52787/NDNI4913
Tatiana Uehara, Harumi Hashimoto, Federico Bazán, Adriana Tévez, Gladys Bravo, S. Schaab, J. Sordá
Background and aims. The appropriate diagnosis of irritable bowel syndrome is critical due to its association with impaired quality of life and high health care costs. We aim to explore the proportion of subjects with irritable bowel syndrome by the Rome IV criteria at a tertiary care center and compare them with previous diagnostic criteria. Material and methods. We conducted a cross-sectional descriptive study in a tertiary care center located in Buenos Aires. There were included to the consecutive adult patients who consulted for abdominal disorders and in whom an organic pathology had been excluded. Subjects completed a gastrointestinal symptom questionnaire and the proportion of patients with IBS, according to Roma IV criteria, was compare with the proportion of those who met the previous criteria (Manning, Rome I, II and III). Results. Of 178 patients included, 58% met the diagnosis criteria for IBS using the Rome IV criteria. Of these, 98% were also Rome III positive, 76.7% IBS Rome II positive, 93% IBS Rome I positive and 99% IBS Manning positive. The agreement was very good with Rome III (kappa = 0.87), good with Rome I (kappa = 0.76) and good, but lower with Rome II (kappa = 0.73) and Manning (kappa = 0.66). Conclusions. Good diagnostic agreement was established between Rome IV and the previous IBS criteria, except with Rome II and Manning, which were lower.
背景和目的。肠易激综合征的适当诊断至关重要,因为它与生活质量受损和高昂的医疗费用有关。我们的目的是探索在三级护理中心根据罗马IV标准患有肠易激综合征的受试者的比例,并将其与以前的诊断标准进行比较。材料和方法。我们在布宜诺斯艾利斯的一家三级护理中心进行了一项横断面描述性研究。纳入了连续的成年患者,他们咨询了腹部疾病,并排除了器质性病理。受试者完成了胃肠道症状问卷,根据Roma IV标准,将IBS患者的比例与符合先前标准(Manning,Rome I,II和III)的患者比例进行比较。后果在纳入的178名患者中,58%符合罗马IV标准的IBS诊断标准。其中,98%也是罗马III型阳性,76.7%是IBS罗马II型阳性,93%是IBS罗马I型阳性,99%是IBS曼宁型阳性。与Rome III(kappa=0.87)、与Rome I(kappa0.76)和良好的一致性非常好,但与Rome II(kappa.73)和Manning(kappa0.66)的一致性较低。结论。Rome IV和之前的IBS标准之间建立了良好的诊断一致性,但Rome II和Manning标准较低。
{"title":"Comparación entre los criterios diagnósticos del síndrome de intestino irritable en una población latinoamericana. Estudio descriptivo de un centro de atención terciaria","authors":"Tatiana Uehara, Harumi Hashimoto, Federico Bazán, Adriana Tévez, Gladys Bravo, S. Schaab, J. Sordá","doi":"10.52787/NDNI4913","DOIUrl":"https://doi.org/10.52787/NDNI4913","url":null,"abstract":"Background and aims. The appropriate diagnosis of irritable bowel syndrome is critical due to its association with impaired quality of life and high health care costs. We aim to explore the proportion of subjects with irritable bowel syndrome by the Rome IV criteria at a tertiary care center and compare them with previous diagnostic criteria. Material and methods. We conducted a cross-sectional descriptive study in a tertiary care center located in Buenos Aires. There were included to the consecutive adult patients who consulted for abdominal disorders and in whom an organic pathology had been excluded. Subjects completed a gastrointestinal symptom questionnaire and the proportion of patients with IBS, according to Roma IV criteria, was compare with the proportion of those who met the previous criteria (Manning, Rome I, II and III). Results. Of 178 patients included, 58% met the diagnosis criteria for IBS using the Rome IV criteria. Of these, 98% were also Rome III positive, 76.7% IBS Rome II positive, 93% IBS Rome I positive and 99% IBS Manning positive. The agreement was very good with Rome III (kappa = 0.87), good with Rome I (kappa = 0.76) and good, but lower with Rome II (kappa = 0.73) and Manning (kappa = 0.66). Conclusions. Good diagnostic agreement was established between Rome IV and the previous IBS criteria, except with Rome II and Manning, which were lower.","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49534602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hallazgo incidental postrauma abdominal 腹部创伤后意外发现
Q4 Medicine Pub Date : 2021-06-21 DOI: 10.52787/XORO6319
Diana Marcela Rodríguez De La Hoz, M. Alvarez, M. Orozco, María De Vedia, Nicolás Roccatagliata, R. Cobeñas, N. Larrañaga
{"title":"Hallazgo incidental postrauma abdominal","authors":"Diana Marcela Rodríguez De La Hoz, M. Alvarez, M. Orozco, María De Vedia, Nicolás Roccatagliata, R. Cobeñas, N. Larrañaga","doi":"10.52787/XORO6319","DOIUrl":"https://doi.org/10.52787/XORO6319","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42124253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complicación posretrasplante hepático
Q4 Medicine Pub Date : 2021-06-21 DOI: 10.52787/FRCX4140
M. Bello, N. Larrañaga, G. Espil, S. Kozima, Fabiana Prado
{"title":"Complicación posretrasplante hepático","authors":"M. Bello, N. Larrañaga, G. Espil, S. Kozima, Fabiana Prado","doi":"10.52787/FRCX4140","DOIUrl":"https://doi.org/10.52787/FRCX4140","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43326024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solución del caso. Complicación posretrasplante hepático 案件的解决。肝移植后并发症
Q4 Medicine Pub Date : 2021-06-21 DOI: 10.52787/ZPRY7802
M. Bello, N. Larrañaga, G. Espil, S. Kozima, Fabiana Prado
{"title":"Solución del caso. Complicación posretrasplante hepático","authors":"M. Bello, N. Larrañaga, G. Espil, S. Kozima, Fabiana Prado","doi":"10.52787/ZPRY7802","DOIUrl":"https://doi.org/10.52787/ZPRY7802","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48151392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hallazgo radiológico infrecuente por una hiperpresión abdominal tras un traumatismo 创伤后腹部高压的罕见放射学发现
Q4 Medicine Pub Date : 2021-03-22 DOI: 10.52787/HMYJ6165
María del Mar Roldán Alcázar, A. M. Maldonado, A. S. Gutiérrez, C. Cejudo
{"title":"Hallazgo radiológico infrecuente por una hiperpresión abdominal tras un traumatismo","authors":"María del Mar Roldán Alcázar, A. M. Maldonado, A. S. Gutiérrez, C. Cejudo","doi":"10.52787/HMYJ6165","DOIUrl":"https://doi.org/10.52787/HMYJ6165","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46935418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importancia de la clasificación de obesidad en la tasa de erradicación de Helicobacter pylori 肥胖分类对幽门螺杆菌根除率的重要性
Q4 Medicine Pub Date : 2021-03-22 DOI: 10.52787/VFOY2155
Bryan Cuzcano Villalobos, Kevin Quinteros Figueroa, Jorge Enrique Osada Liy
{"title":"Importancia de la clasificación de obesidad en la tasa de erradicación de Helicobacter pylori","authors":"Bryan Cuzcano Villalobos, Kevin Quinteros Figueroa, Jorge Enrique Osada Liy","doi":"10.52787/VFOY2155","DOIUrl":"https://doi.org/10.52787/VFOY2155","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47608233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tratamiento de hepatitis crónica por virus de Hepatitis C con drogas antivirales de acción directa en un paciente con fibrosis quística 用直接作用抗病毒药物治疗囊性纤维化患者慢性丙型肝炎
Q4 Medicine Pub Date : 2021-03-22 DOI: 10.52787/TZDH9217
J. D. Bosia, María Virginia D´Ascenzo, Silvia Borzi, E. Barán, María Cecilia Calzona
The development of new direct acting antiviral drugs for the treatment of Hepatitis C virus infection, has made it possible to obtain an excellent cure rate and extend the indications for eradication of Hepatitis C virus to previously very difficult populations to treat like cystic fibrosis, in whom treatment with classic regimens based on pegylated Interferon plus ribavirin could favor worsening lung function. We present a case of a 41-year-old man with cystic fibrosis, diagnosed with Hepatitis C virus infection, genotype 1a, non-cirrhotic, treated with direct acting antiviral drugs for twelve weeks, obtaining a sustained viral response, without adverse effects. One year later, being on the waiting list, underwent a bipulmonary transplant.
用于治疗丙型肝炎病毒感染的新型直接作用抗病毒药物的开发,使得有可能获得良好的治愈率,并将根除丙型肝炎病毒的适应症扩展到以前非常难以治疗的人群,如囊性纤维化,在这些人群中,基于聚乙二醇化干扰素加利巴韦林的经典治疗方案可能会导致肺功能恶化。我们报告一例41岁男性囊性纤维化,诊断为丙型肝炎病毒感染,基因型1a,非肝硬化,接受直接作用抗病毒药物治疗12周,获得持续的病毒反应,无不良反应。一年后,由于在等待名单上,她接受了双肺移植手术。
{"title":"Tratamiento de hepatitis crónica por virus de Hepatitis C con drogas antivirales de acción directa en un paciente con fibrosis quística","authors":"J. D. Bosia, María Virginia D´Ascenzo, Silvia Borzi, E. Barán, María Cecilia Calzona","doi":"10.52787/TZDH9217","DOIUrl":"https://doi.org/10.52787/TZDH9217","url":null,"abstract":"The development of new direct acting antiviral drugs for the treatment of Hepatitis C virus infection, has made it possible to obtain an excellent cure rate and extend the indications for eradication of Hepatitis C virus to previously very difficult populations to treat like cystic fibrosis, in whom treatment with classic regimens based on pegylated Interferon plus ribavirin could favor worsening lung function. We present a case of a 41-year-old man with cystic fibrosis, diagnosed with Hepatitis C virus infection, genotype 1a, non-cirrhotic, treated with direct acting antiviral drugs for twelve weeks, obtaining a sustained viral response, without adverse effects. One year later, being on the waiting list, underwent a bipulmonary transplant.","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71004760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Gastroenterologica Latinoamericana
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1